Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-07-27

Clinical Trial Update: Efficacy and Safety of Leningrado Association in the Treatment of Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Leningrado Association for arterial hypertension was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leningrado Association

Snippet

Sponsor: EMS | Conditions: Arterial Hypertension | Phase 3 | Status: WITHDRAWN